Dmitry Kaminskiy

Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.

 

Mr. Kaminskiy is a Сo-Founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.

 

He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.

 

Mr. Kaminskiy is a frequent speaker on the topics of AI and Longevity at conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities.

He was actively involved in the work of the initiative group and was instrumental at the initial stage of the launch of Longevity International CIC, the secretariat for the All-Party Parliamentary Group for Longevity in the UK Parliament (the world's first Longevity-focused parliamentary group), and served as a Co-Founder of the APPG’s Secretariat from 2019-2021.

 

Mr. Kaminskiy is also Co-Founder of Aging Analytics Agency, Deep Knowledge Group’s dedicated Longevity-focused analytical subsidiary, which currently serves as an official member organisation of the United Nations NGO Committee on Ageing and regularly submits policy and strategy proposals to the World Health Organization, World Economic Forum, the UK House of Lords and other national and international policy organizations.

 

He also supervises the activities of Deep Knowledge group’s 10+ other analytical subsidiaries, including Deep Knowledge Analytics, Deep Pharma Intelligence, NeuroTech Analytics, FemTech Analytics, SpaceTech Analytics, InvestTech Advanced Solutions, Longevity Financial Advisors, Deep Knowledge Analytics GovTech / E-Governance Division, Deep Knowledge Analytics COVID-19 Analytics Division, and Innovation Eye (a joint venture between Deep Knowledge Analytics and Big Innovation Centre, the Secretariat for the UK All-Party Parliamentary Groups on Artificial Intelligence and Blockchain).

 

In addition to his business activities, Dmitry is involved in several scientific endeavors. He strongly believes that humans should live longer healthier lives. He has a major interest in Healthy Longevity which is reflected in his business, research and public activities.

 

His $1 million prize for the first person to reach their 123rd birthday went viral, and was widely covered by the world’s top media. The current lifespan record is 122.5 years, achieved by Jeanne Calment in 1997, which has remained unchanged despite the tremendous advances in biomedicine and in our understanding of the aging process that have occurred since that time.

 

He chose to launch this prize in order to promote Healthy Longevity, and to motivate people to maximize their own Healthy Longevity. Given the dynamic of progress in the field of Longevity, it is only a matter of time before this record is surpassed through the proactive efforts of someone using all available resources, both scientific, technological and lifestyle-related, to maximize their Healthy Longevity and celebrate his or her 123rd birthday.

Mr. Kaminskiy is also author of the critically acclaimed book, Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, published in 2020, which distilled the complex assembly of deep market intelligence and industry knowledge that Deep Knowledge Group and its Longevity-focused subsidiaries have developed over the past 7 years into a full-scope understanding of the Global Longevity Industry, sufficient to define the industry for the first time and to reliably forecast its future development. His newest book, Biomarkers of Human Longevity: Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking, was published 2021.